| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 5, 2004
From the Frontier Health Science (J.-W.X., K.I.), School of Human Environmental Science and Research Center for Life-Style Related Diseases (J.-W.X., K.I.), MUKOGAWA Women’s University, Nishinomiya; WHO Collaborating Center for Research on Primary Prevention of Cardiovascular Diseases (Y.Y.), Kyoto, Japan. * To whom correspondence should be addressed. E-mail: jwxu{at}mwu.mukogawa-u.ac.jp.
Abstract--Endothelial nitric oxide synthase (eNOS) plays an important role in maintaining blood pressure homeostasis and vascular integrity. Natural dietary flavoniods are thought to protect against cardiovascular diseases by acting as antioxidants and vasodilatants. This study examined the effect of cyanidin-3-glucoside (Cy3G), a typical anthocyanin pigment, on eNOS expression. Treatment of bovine artery endothelial cells (BAECs) with Cy3G for 8 hours of enhanced eNOS protein expression in a dose- and time-dependent manner was determined by Western blot analysis. Longer incubation (12, 16, and 24 hours) of BAECs with 0.1 µmol/L of Cy3G caused a further increase in eNOS expression, and subsequently Cy3G also significantly increased nitric oxide output 2-fold (24 hours). Furthermore, Cy3G stimulated the phosphorylation of Src and extracellular signal-regulated kinase 1/2 (ERK1/2) in a time-dependent manner. An Src kinase inhibitor, pp2, and MEK inhibitor, PD98059, blocked the ERK1/2 phosphorylation and eNOS expression. Transfection with dominant-negative Src cDNA also inhibited the eNOS expression stimulated by Cy3G. In addition, stimulation with Cy3G for 30 minutes resulted in a phosphorylation of Sp1 that was blocked by PD98059. Cy3G enhanced the binding activity of the transcription factor Sp1 to the GC box in the proximal eNOS promoter of BAECs, as revealed by chromatin immunoprecipitation assay. The present study demonstrated that Cy3G induced eNOS expression and escalated NO production via an Src-ERK1/2-Sp1 signaling pathway in vascular endothelial cells. Increased eNOS expression may help to ameliorate endothelial dysfunction, harmonize blood pressure, and prevent atherosclerosis as long-term beneficial effects of flavoniods.
Revised on May 28, 2004
Upregulation of Endothelial Nitric Oxide Synthase by Cyanidin-3-Glucoside, a Typical Anthocyanin Pigment
Jin-Wen Xu*;
This article has been cited by other articles:
![]() |
Y. Qin, M. Xia, J. Ma, Y. Hao, J. Liu, H. Mou, L. Cao, and W. Ling Anthocyanin supplementation improves serum LDL- and HDL-cholesterol concentrations associated with the inhibition of cholesteryl ester transfer protein in dyslipidemic subjects Am. J. Clinical Nutrition, September 1, 2009; 90(3): 485 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gao, C.-L. Long, R.-H. Wang, and H. Wang KATP activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function Cardiovasc Res, August 1, 2009; 83(3): 444 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Y. Chen, H.-M. Chu, K.-T. Pan, C.-H. Teng, D.-L. Wang, A. H.-J. Wang, K.-H. Khoo, and T.-C. Meng Cysteine S-Nitrosylation Protects Protein-tyrosine Phosphatase 1B against Oxidation-induced Permanent Inactivation J. Biol. Chem., December 12, 2008; 283(50): 35265 - 35272. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kumar, X. Sun, S. Wedgwood, and S. M. Black Hydrogen peroxide decreases endothelial nitric oxide synthase promoter activity through the inhibition of AP-1 activity Am J Physiol Lung Cell Mol Physiol, August 1, 2008; 295(2): L370 - L377. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Mann, D. J. Rowlands, F. Y.L. Li, P. de Winter, and R. C.M. Siow Activation of endothelial nitric oxide synthase by dietary isoflavones: Role of NO in Nrf2-mediated antioxidant gene expression Cardiovasc Res, July 15, 2007; 75(2): 261 - 274. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Bell and K. Gochenaur Direct vasoactive and vasoprotective properties of anthocyanin-rich extracts J Appl Physiol, April 1, 2006; 100(4): 1164 - 1170. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Grassi, S. Necozione, C. Lippi, G. Croce, L. Valeri, P. Pasqualetti, G. Desideri, J. B. Blumberg, and C. Ferri Cocoa Reduces Blood Pressure and Insulin Resistance and Improves Endothelium-Dependent Vasodilation in Hypertensives Hypertension, August 1, 2005; 46(2): 398 - 405. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |